ACRO
LIVE

Serial Number

90357700

Owner

Acro Biomedical Co., Ltd.

Attorney

Paul A. McLean

Filing Date

Dec 3, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ACRO Trademark

Serial Number: 90357700 • Registration: 6642643

ACRO is a trademark filed by Acro Biomedical Co., Ltd. on December 3, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Acro Biomedical Co., Ltd. (9 trademarks)

Suite 1160
Fishers, IN 46038

Entity Type: 03

Trademark Details

Filing Date

December 3, 2020

Registration Date

February 15, 2022

Published for Opposition

November 30, 2021

Goods & Services

Biological human living tissue grafts; surgical implants comprised of living tissues; medicines for human purposes, namely, antibiotics and growth factors for use in tissue engineering and regenerative medicine, and cell therapies; preparations to facilitate teething, namely, gels, paste, and putty; medicines for dental purposes, bone cement for surgical purposes; bone cement for orthopaedic purposes; materials for dressings, namely, wound healing material in the nature of matrix, wound dressing, decellular dermis in the nature of matrix, hemostatic dressings to control bleeding, hemostatic powder, hemostatic materials in the nature of matrix; grafting gums in the nature of matrix, namely, medicated gum for medical purposes; absorbent wadding for medical purposes; suture materials, namely, tapes for skin suture; teeth filling materials; medicines for veterinary purposes, namely, antibiotics and growth factors for use in tissue engineering and regenerative medicine, and cell therapy; medical trauma dressing for animals; biological tissue cultures for veterinary purposes; stem cells for veterinary purposes; hygienic eye patches and wound patches for medical purposes; biological tissue cultures for medical purposes, namely, tissue regeneration membrane for dental, medical, and surgical anti-adhesive use; injectable dermal fillers

Albumin for use in the manufacture of skin care product; animal albumen for use in the manufacture of skin care product; protein for use in the manufacture of skin care product; chemical preparations, other than for medical or veterinary purposes for scientific use; chemical reagents for non-medical purposes; stem cells, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes

Coronary stents; implantable nerve scaffolds made of collagen protein for neuron regeneration and neuron repair; blood vessel prostheses; implants, namely, artificial eyes, artificial heart, artificial liver, artificial kidney, artificial pancreas, artificial lung, artificial intestines; intravascular stents; artificial skins for surgical purposes; surgical cornea implants comprised of non-living tissue; artificial skins comprised of non-living tissue; surgical implants comprised of artificial materials; biodegradable bone-fixation implants; medical apparatus, namely, apparatus for surgical uses; cosmetic apparatus using ultrasound for performing aesthetic skin treatment procedures; medical instruments, namely, apparatus for surgical uses; cosmetic apparatus using ultrasound for performing aesthetic skin treatment procedures; testing apparatus for medical purposes, namely, apparatus for aesthetic and surgical uses in the nature of immunochemical testing apparatus for medical use, medical diagnostic apparatus for testing DNA and RNA samples, organoleptic diagnostic testing apparatus for medical use; artificial absorbable sutures; suture materials; massage apparatus

Filing History

REGISTERED-PRINCIPAL REGISTER
Feb 15, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 30, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 30, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 10, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 26, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 15, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 14, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 14, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 9, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jun 9, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jun 9, 2021 CNRT
ASSIGNED TO EXAMINER
May 20, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 9, 2021 NWOS
NEW APPLICATION ENTERED
Dec 7, 2020 NWAP